| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TALPHERA, INC. | Chief Financial Officer | Common Stock | 37.7K | $41.5K | $1.10 | Mar 3, 2024 | Direct |
| TALPHERA, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 108K | Feb 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TLPH | TALPHERA, INC. | Mar 3, 2024 | 1 | -$725 | 4 | Mar 4, 2024 | Chief Financial Officer |
| TLPH | TALPHERA, INC. | Feb 14, 2024 | 2 | $0 | 4 | Feb 27, 2024 | Chief Financial Officer |
| TLPH | TALPHERA, INC. | Feb 10, 2024 | 2 | -$1.97K | 4 | Feb 13, 2024 | Chief Financial Officer |
| ACRX | ACELRX PHARMACEUTICALS INC | Mar 3, 2023 | 1 | -$668 | 4 | Mar 6, 2023 | Chief Financial Officer |
| ACRX | ACELRX PHARMACEUTICALS INC | Feb 10, 2023 | 3 | -$1.47K | 4 | Feb 14, 2023 | Chief Financial Officer |
| ACRX | ACELRX PHARMACEUTICALS INC | Feb 6, 2023 | 1 | -$1.25K | 4 | Feb 8, 2023 | Chief Financial Officer |
| ACRX | ACELRX PHARMACEUTICALS INC | Mar 3, 2022 | 1 | -$3.22K | 4 | Mar 4, 2022 | Chief Financial Officer |
| ACRX | ACELRX PHARMACEUTICALS INC | Feb 11, 2022 | 3 | -$3.18K | 4 | Feb 14, 2022 | Chief Financial Officer |
| ACRX | ACELRX PHARMACEUTICALS INC | Feb 6, 2022 | 1 | -$4.05K | 4 | Feb 7, 2022 | Chief Financial Officer |